Restriction Enzyme Analysis of Ribosomal DNA Shows that Candida inconspicua Clinical Isolates Can Be Misidentified as Candida norvegensis with Traditional Diagnostic Procedures
Open Access
- 1 November 2003
- journal article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 41 (11) , 5250-5253
- https://doi.org/10.1128/jcm.41.11.5250-5253.2003
Abstract
We identified 29 yeast isolates from 22 patients using the API ID32C panel. Twenty-eight of these isolates were Candida norvegensis and one was C. inconspicua . Although C. norvegensis is considered a pseudohypha-producing species, only one isolate produced pseudohyphae. Restriction enzyme analysis of PCR-amplified ribosomal DNA with four different enzymes proved that all isolates were C. inconspicua .Keywords
This publication has 18 references indexed in Scilit:
- A ten-minute DNA preparation from yeast efficiently releases autonomous plasmids for transformaion of Escherichia coliPublished by Elsevier ,2003
- Distribution and susceptibility of Candida species isolated in the Medical University of DebrecenActa Microbiologica Et Immunologica Hungarica, 2002
- Antifungal drug resistance of pathogenic fungiThe Lancet, 2002
- Candida glabrata : Review of Epidemiology, Pathogenesis, and Clinical Disease with Comparison to C. albicansClinical Microbiology Reviews, 1999
- Candida BerkhoutPublished by Elsevier ,1998
- Pichia E.C. Hansen emend. KurtzmanPublished by Elsevier ,1998
- Issatchenkia Kudryavtsev emend. Kurtzman, Smiley & JohnsonPublished by Elsevier ,1998
- Molecular genetic approaches to identification, epidemiology and taxonomy of non-albicans Candida speciesJournal of Medical Microbiology, 1996
- Karyotyping of Fluconazole-Resistant Yeasts with Phenotype Reported as Candida krusei or Candida inconspicuaInternational Journal of Systematic and Evolutionary Microbiology, 1996
- Candida krusei: biology, epidemiology, pathogenicity and clinical manifestations of an emerging pathogenJournal of Medical Microbiology, 1994